GB202216373D0 - Chromen-4-one compounds with anticancer properties - Google Patents

Chromen-4-one compounds with anticancer properties

Info

Publication number
GB202216373D0
GB202216373D0 GBGB2216373.7A GB202216373A GB202216373D0 GB 202216373 D0 GB202216373 D0 GB 202216373D0 GB 202216373 A GB202216373 A GB 202216373A GB 202216373 D0 GB202216373 D0 GB 202216373D0
Authority
GB
United Kingdom
Prior art keywords
chromen
compounds
anticancer properties
anticancer
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2216373.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Floratek Pharma SA
Original Assignee
Floratek Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Floratek Pharma SA filed Critical Floratek Pharma SA
Priority to GBGB2216373.7A priority Critical patent/GB202216373D0/en
Publication of GB202216373D0 publication Critical patent/GB202216373D0/en
Priority to PCT/EP2023/080721 priority patent/WO2024094875A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2216373.7A 2022-11-03 2022-11-03 Chromen-4-one compounds with anticancer properties Pending GB202216373D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2216373.7A GB202216373D0 (en) 2022-11-03 2022-11-03 Chromen-4-one compounds with anticancer properties
PCT/EP2023/080721 WO2024094875A1 (en) 2022-11-03 2023-11-03 Chromen-4-one compounds with anticancer properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2216373.7A GB202216373D0 (en) 2022-11-03 2022-11-03 Chromen-4-one compounds with anticancer properties

Publications (1)

Publication Number Publication Date
GB202216373D0 true GB202216373D0 (en) 2022-12-21

Family

ID=84839662

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2216373.7A Pending GB202216373D0 (en) 2022-11-03 2022-11-03 Chromen-4-one compounds with anticancer properties

Country Status (2)

Country Link
GB (1) GB202216373D0 (en)
WO (1) WO2024094875A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10111854B2 (en) * 2014-02-26 2018-10-30 The Hong Kong Polytechnic University Synthesis and use of amine-containing flavonoids as potent anti-leishmanial agents
WO2015161309A1 (en) * 2014-04-19 2015-10-22 Jia Zhou Apigenin analogs, compositions, and methods related thereto
GB202101728D0 (en) * 2021-02-08 2021-03-24 Floratek Pharma Ag Compounds and their use treating cancer
GB202104122D0 (en) * 2021-03-24 2021-05-05 Floratek Pharma Ag Compounds and their use

Also Published As

Publication number Publication date
WO2024094875A1 (en) 2024-05-10

Similar Documents

Publication Publication Date Title
IL254025A0 (en) Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
CA203138S (en) Bracket
IL309099A (en) Anticancer compounds
CA204474S (en) Bracket
EP4251625A4 (en) Tricyclic compounds
EP3261629A4 (en) Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
ZA202303688B (en) Substituted tricyclic compounds
IL287813A (en) Tricyclic compounds
GB202216373D0 (en) Chromen-4-one compounds with anticancer properties
IL286600A (en) Antitumor composition
SG11202104832VA (en) Anticancer composition
GB202104274D0 (en) Anticancer compounds
GB202004321D0 (en) Anticancer compounds
GB202204285D0 (en) Anticancer compounds
GB201904544D0 (en) Anticancer compounds
CA205342S (en) Bracket
CA204478S (en) Bracket
CA204471S (en) Bracket
CA203481S (en) Bracket
GB2603460B (en) Bracket
GB2601807B (en) Bracket
CA198785S (en) Bracket
CA198786S (en) Bracket
CA198783S (en) Bracket
CA198784S (en) Bracket